FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16614411000001108: Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Mar 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
58603201000001114 Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58603301000001117 Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Is a Levonorgestrel 150microgram / Ethinylestradiol 30microgram tablets 63 tablet true Inferred relationship Existential restriction modifier
Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has AMP Levest 150/30 tablets (Morningside Healthcare Ltd) true Inferred relationship Existential restriction modifier
Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Levonorgestrel true Inferred relationship Existential restriction modifier
Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Levest 150/30 tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start